Event image
COVID-19
April 26, 2021
US denies India's request to lift an export ban on raw materials needed to make COVID-19 vaccines
The US State Department said that the US is focusing on vaccinating the American people when asked about sending raw materials to India for vaccine production. The response comes after the Serum Institute of India asked the US to lift an export ban on these materials, a request that has yet to be met. India is currently facing a large surge in COVID-19 cases with over 300,000 new cases recorded in one day this week. Some estimates suggest that the US export ban could last another month.
Photo via @StuartLWallace

US denies India's request to lift an export ban on raw materials needed to make COVID-19 vaccines

#USA has invoked the Defense Production Act to preserve vaccine raw materials for its own companies, but the Serum Institute of #India (SII), the world's biggest #vaccine maker, has said this went against the global goal of sharing vaccines equitably.
92
1,621
Amid ghastly scenes of India's health system collapsing, the country's biggest vaccine maker asked President Bident to lift a ban on export materials, so that India can ramp up production. Here's the US State Dept's response.
Quote Tweet
"United States first and foremost is engaged in an ambitious and effective and, so far, successful effort to vaccinate the American people", US State Dept when asked about #COVID vaccine raw materials export to India
Show this thread
Embedded video
2:20
816.2K views
673
3,441
Business profile picture
India reported a global record of more than 332,000 new infections Friday as a grim COVID surge in the world's second-most populous country sends more and more sick people into a fragile health care system. "It's terrifying to live in a city," reports from Delhi.
170
883
India is experiencing a massive surge in COVID-19 cases and oxygen supplies are running low in the country

You’re up to date